Hepatology

Top Story

First patient enrolled in proof-of-concept trial for PSC treatment

August 19, 2019

Wyanoke Group announces Healio rebranding

August 19, 2019
In an effort to improve the user experience for its health provider audiences, the Wyanoke Group is rebranding its live event, digital and publishing arms under the…

Terlipressin reverses hepatorenal syndrome in phase 3 trial

August 19, 2019
Initial results from a phase 3 clinical study of terlipressin showed that the therapy met its primary endpoint of “verified” hepatorenal syndrome type 1…
Feature

Analysts debate Senate drug pricing bill’s likelihood of making an impact

August 19, 2019
The Prescription Drug Pricing Reduction Act, introduced last month by Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden
In the Journals

Models calculate risk for post-hepatectomy liver failure in cirrhosis

August 17, 2019
A pair of preoperative and postoperative models estimated the probabilities for post-hepatectomy liver failure in patients with cirrhosis, according to a recently…
More Headlines »
CME

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Resource Centers
International Liver Congress

International Liver Congress

Video
Meeting News

VIDEO: Revita DMR procedure improves liver, cardiovascular parameters

May 3, 2019
More »
Current Issues Current Issues
View the Current Issue
HCV Next